DATE
17/03/2023
TOTAL VIEWS
2262

Share to Social media

Welcome Note


Dear Healthcare Professionals,

Acute Hepatic Porphyria (AHP) is a family of rare and debilitating genetic diseases that is characterized by painful and progressive neurovisceral attacks and chronic symptoms between attacks. This ultra-rare genetic disease is often mistaken for conditions such as irritable bowel syndrome, Crohn’s disease, fibromyalgia, polyneuropathy, endometriosis and even psychiatric disorders. As a result, people may experience delays of up to 15 years before receiving a correct diagnosis and appropriate treatment.

On the 17th of March, top experts in the field of Porphyrias and experienced specialists from Europe and Latin America, will meet in-person and virtually to discuss how to recognize the typical signs of AHP, how to accurately diagnose and how to optimally manage the disease in clinical practice. Through short lectures, case presentations and open-panel discussion sessions, this educational event will address the challenges in early diagnosis and latest advances in the treatment of AHP.

Join us virtually on the 17th of March to learn when to consider AHP, how to confirm your suspicions, ask the experts and share knowledge and opinions with your peers.

Yours Sincerely,

The Genesis Pharma team


This medical educational event is open only for Healthcare Professionals from selected countries.

The event is organized and sponsored by Genesis Pharma.

Create password / Are you missing your password?

Welcome Note


Dear Healthcare Professionals,

Acute Hepatic Porphyria (AHP) is a family of rare and debilitating genetic diseases that is characterized by painful and progressive neurovisceral attacks and chronic symptoms between attacks. This ultra-rare genetic disease is often mistaken for conditions such as irritable bowel syndrome, Crohn’s disease, fibromyalgia, polyneuropathy, endometriosis and even psychiatric disorders. As a result, people may experience delays of up to 15 years before receiving a correct diagnosis and appropriate treatment.

On the 17th of March, top experts in the field of Porphyrias and experienced specialists from Europe and Latin America, will meet in-person and virtually to discuss how to recognize the typical signs of AHP, how to accurately diagnose and how to optimally manage the disease in clinical practice. Through short lectures, case presentations and open-panel discussion sessions, this educational event will address the challenges in early diagnosis and latest advances in the treatment of AHP.

Join us virtually on the 17th of March to learn when to consider AHP, how to confirm your suspicions, ask the experts and share knowledge and opinions with your peers.

Yours Sincerely,

The Genesis Pharma team


This medical educational event is open only for Healthcare Professionals from selected countries.

The event is organized and sponsored by Genesis Pharma.